创建报告

请提供报告标题
请提供位置
请提供详细信息

添加更多

获取有关您案例的警报和更新!

这些信息不会显示在网站上。我们可以通知您更新,并可能与您联系以获取更多信息,以帮助您解决或跟进您的问题。

请提供电子邮件或电话
请提供电子邮件或电话

我们不会显示您的电子邮件或联系信息

跳过此步骤

添加照片或视频

我们推荐照片和视频来帮助您解释报告

添加照片/视频
将文件放到此处
跳过此步骤

报告的电子邮件或短信副本

在下面输入以获取您的报告副本的电子邮件,或短信指向您的报告的链接

请提供电子邮件或电话
请提供电子邮件或电话

感谢您的举报!

重要信息-您的报告已排队可能需要 12 个小时才能在我们的主页上显示您的报告(如果没有选择为私人)


报告已成功发送!



您的报告已排队——处理您的报告最多可能需要 12 个小时。


如果您有疑问,请发送电子邮件至 support@safelyhq.com。

Recall notice

氯化钾注射液因氯化钾过量而召回, USA

2个月前 source fda.gov

United States

Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq with NDC 0990-7074-26. Otsuka ICU Medical LLC has identified this discrepancy due to a manufacturing issue. The dosage is correctly printed on the labeling affixed to the product bag which is not visible when the 10 mEq OVERWRAP is in place. This notification details the issue and the required steps for you to perform. The affected product lot was manufactured on 15 April 2025 and distributed in the United States between 23 May 2025 through 26 August 2025.

If the incorrect dosage on the 10 mEq overwrap is used instead of the correct 20mEq dosage printed on the product, an overdose of potassium chloride is possible. Overdose of potassium chloride can lead to hyperkalemia. Hazards of severe hyperkalemia after large intravenous overdoses causes neuromuscular dysfunction including muscle weakness, ascending paralysis, listlessness, vertigo, mental confusion, hypotension, cardiac dysrhythmias, or death from cardiac arrest. Premature infants, patients on chronic parenteral nutrition, patients who have a history of cardiac arrythmias, patients with chronic renal insufficiency, patients who have acute renal failure, patients on potassium-sparing diuretics—all are at risk for adverse and potentially fatal outcomes. Otsuka ICU Medical LLC has not received reports of adverse events associated with this issue to date.

The affected product lot (Located on the top left of the product bag or the case label is:

- NDC NUMBER: 0990-7077-14
- LIST NUMBER: 070770452
- PRODUCT: Potassium Chloride Injection 20 mEq
- LOT NUMBER: 1030613
- EXPIRATION DATE: September 30, 2026
- CONFIGURATION: 50 mL in Flexible Container

- NDC NUMBER: 0990-7074-26
- LIST NUMBER: 070740452
- PRODUCT: Potassium Chloride Injection 10 mEq
- LOT NUMBER: N/A
- EXPIRATION DATE: N/A
- CONFIGURATION: 100 mL in Flexible Container

DESCRIPTION OF CASES BEING RECALLED:

- NDC NUMBER: 0990-7077-14
- BARCODE NUMBER: (01)20309907077141
- LOT NUMBER: 1030613
- EXPIRATION DATE: September 30, 2026
- CONFIGURATION: 24 per case

The U.S. Food and Drug Administration (FDA) has been notified of this action.

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-20-meq-potassium-chloride-injection-due

#drugs #unitedstates

我附近的最新报告